• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MOLECULAR, INC. ALINITY M SYSTEM; REAL TIME NUCLEIC ACID AMPLIFICATION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MOLECULAR, INC. ALINITY M SYSTEM; REAL TIME NUCLEIC ACID AMPLIFICATION SYSTEM Back to Search Results
Model Number 08N53-002
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/29/2020
Event Type  malfunction  
Manufacturer Narrative
Elevated complaint investigation will be performed.
 
Event Description
Customer called reporting an aspiration issue on some sample tubes when running the alinity m sars-cov-2 assay on their alinity m system.On (b)(6) 2020, customer observed that samples tubes were not aspirated.The volume (1 ml) before the run is the same after the run.The instrument didn´t give any error code.Customer is concerned because all tubes not aspirated were reported as negatives, which could lead to false negative results.Customer confirmed that in sars-cov-2 protocol they always put 1ml of patient sample.Customer was advised to check patient sample tubes to see if there were any bubble, and repeat the tube in question.All samples were repeated the same day, aspirated correctly and generated negative results.There was no impact to patient management as the samples all repeated as negative.Field service engineer (fse) completed a file analysis.Based on log review, samples appear to have been properly aspirated by the instrument.Evaluation will be written as a worst case false negative sars-cov-2 result.This incident is being reported to fda because the incident occurred in (b)(6) using the alinity m system, list 8n53-02, which is also us fda approved.
 
Manufacturer Narrative
Investigation into this complaint included a customer data review, a nonconformance/ capa history review and a complaint history review.The investigation is summarized as follows: log file analysis revealed proper pipettor aspiration.Samples were repeated the same day and reported the same test results as negatives.The nonconformance/capa (corrective and preventative action) search did not find any records related to false negative results received from samples that had not been aspirated on an alinity m system.The complaint history review found 1 additional complaint ticket related to false negative results received from samples that had not been aspirated on an alinity m system.Based on the results of the investigation, a product deficiency was not identified for the alinity m system (ln 08n53-02).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY M SYSTEM
Type of Device
REAL TIME NUCLEIC ACID AMPLIFICATION SYSTEM
Manufacturer (Section D)
ABBOTT MOLECULAR, INC.
1300 e. touhy ave.
des plaines IL 60018 3315
MDR Report Key10731854
MDR Text Key213001696
Report Number3005248192-2020-00083
Device Sequence Number1
Product Code OOI
UDI-Device Identifier00884999048034
UDI-Public00884999048034
Combination Product (y/n)N
PMA/PMN Number
P190025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 12/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number08N53-002
Device Catalogue Number08N53-02
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 09/29/2020
Initial Date FDA Received10/24/2020
Supplement Dates Manufacturer Received12/02/2020
Supplement Dates FDA Received12/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-